Glioblastoma—A Contemporary Overview of Epidemiology, Classification, Pathogenesis, Diagnosis, and Treatment: A Review Article
Kinga Królikowska, Katarzyna Błaszczak, Sławomir Ławicki, Monika Zajkowska, Monika Gudowska-Sawczuk · 2025
Read Glioblastoma—A Contemporary Overview of Epidemiology, Classification, Pathogenesis, Diagnosis, and Treatment: A Review Article by Kinga Królikowska, Katarzyna Błaszczak, Sławomir Ławicki, Monika Zajkowska, Monika Gudowska-Sawczuk (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12733314.txt.
Description
Kinga Królikowska and four colleagues survey the current state of glioblastoma, the most common and aggressive primary brain tumor in adults. Their review covers epidemiology, the modern molecular classification, the genetic drivers, diagnosis, and treatment. It draws on studies from 2018 to 2025.
Despite surgery, radiation, and chemotherapy, average survival remains about fifteen months. The tumor's variety, stem-like cells, and an environment that holds the immune system back defeat standard therapy. Molecular markers now anchor diagnosis and treatment grouping under the updated World Health Organization scheme. The authors assess newer tools, liquid biopsy, radiogenomics, and next-generation sequencing, as ways to sharpen decisions for a cancer that has resisted decades of effort.
Catalog record
| CREATOR | Kinga Królikowska, Katarzyna Błaszczak, Sławomir Ławicki, Monika Zajkowska, Monika Gudowska-Sawczuk |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |